CRISPR Therapeutics (CRSP) Short Interest Ratio & Short Volume

$56.41
+0.75 (+1.35%)
(As of 04/23/2024 ET)

CRISPR Therapeutics Short Interest Data

Current Short Volume
14,760,000 shares
Previous Short Volume
14,720,000 shares
Change Vs. Previous Month
+0.27%
Dollar Volume Sold Short
$1.01 billion
Short Interest Ratio / Days to Cover
7.9
Last Record Date
March 31, 2024
Outstanding Shares
84,880,000 shares
Percentage of Shares Shorted
17.39%
Today's Trading Volume
1,185,410 shares
Average Trading Volume
1,254,354 shares
Today's Volume Vs. Average
95%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling CRISPR Therapeutics ?

Sign up to receive the latest short interest report for CRISPR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRSP Short Interest Over Time

CRSP Days to Cover Over Time

CRSP Percentage of Float Shorted Over Time

CRISPR Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202414,760,000 shares $1.01 billion +0.3%N/A7.9 $68.16
3/15/202414,720,000 shares $1.07 billion -2.3%N/A7.4 $72.95
2/29/202415,060,000 shares $1.27 billion +1.3%N/A5.8 $84.22
2/15/202414,870,000 shares $1.26 billion -5.5%N/A5.5 $84.48
1/31/202415,740,000 shares $990.83 million -7.6%N/A5.6 $62.95
1/15/202417,040,000 shares $1.09 billion +4.9%N/A5.8 $64.25
12/31/202316,250,000 shares $1.02 billion -6.2%N/A5.9 $62.60
12/15/202317,330,000 shares $1.08 billion +8.8%N/A6.6 $62.08
11/30/202315,930,000 shares $1.06 billion -2.7%N/A7 $66.73
11/15/202316,370,000 shares $920.49 million +17.9%N/A9.6 $56.23
10/31/202313,890,000 shares $540.74 million +2.5%N/A10.9 $38.93
10/15/202313,550,000 shares $600.40 million +3.9%N/A13.3 $44.31
9/30/202313,040,000 shares $591.89 million -5.4%N/A13.4 $45.39
9/15/202313,790,000 shares $697.50 million -2.1%N/A14.6 $50.58
8/31/202314,080,000 shares $704.14 million +5.0%N/A13.7 $50.01
8/15/202313,410,000 shares $652.80 million +10.7%N/A11.9 $48.68
7/31/202312,110,000 shares $694.27 million -1.6%N/A9.5 $57.33
7/15/202312,310,000 shares $700.56 million -2.1%N/A9.8 $56.91
6/30/202312,570,000 shares $705.68 million +0.8%16.6%9.2 $56.14
6/15/202312,470,000 shares $734.98 million +2.3%16.5%9 $58.94
5/31/202312,190,000 shares $780.65 million -1.9%16.1%9.1 $64.04
5/15/202312,430,000 shares $819.76 million -5.8%16.4%9.5 $65.95
4/30/202313,200,000 shares $646.01 million +1.9%17.5%11.1 $48.94
4/15/202312,950,000 shares $651.51 million +2.0%17.2%11.3 $50.31
3/31/202312,700,000 shares $574.42 million +4.3%16.9%12.2 $45.23
3/15/202312,180,000 shares $547.13 million +9.0%16.2%11.3 $44.92
2/28/202311,170,000 shares $550.90 million +9.0%14.8%10 $49.32
2/15/202310,250,000 shares $534.74 million +2.7%13.7%9.4 $52.17
1/31/20239,980,000 shares $509.18 million +1.0%13.3%9.2 $51.02
1/15/20239,880,000 shares $493.41 million -5.7%13.2%9.1 $49.94
12/30/202210,480,000 shares $426.01 million +12.2%14.0%9.9 $40.65
12/15/20229,340,000 shares $443.65 million -16.2%12.4%8.8 $47.50
11/30/202211,140,000 shares $610.36 million -4.3%14.8%10.6 $54.79
11/15/202211,640,000 shares $710.16 million -7.3%15.5%10.8 $61.01
10/31/202212,550,000 shares $656.87 million +6.7%16.7%11.4 $52.34
10/15/202211,760,000 shares $635.86 million +1.7%15.7%10.4 $54.07
9/30/202211,560,000 shares $755.45 million +5.8%16.1%9.1 $65.35
9/15/202210,930,000 shares $819.86 million +0.5%15.3%7.5 $75.01
8/31/202210,880,000 shares $708.18 million +1.5%15.2%6 $65.09
8/15/202210,720,000 shares $859.10 million -2.3%15.0%5.7 $80.14
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad)

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

CRSP Short Interest - Frequently Asked Questions

What is CRISPR Therapeutics' current short interest?

Short interest is the volume of CRISPR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 14,760,000 shares of CRSP short. Learn More on CRISPR Therapeutics' current short interest.

What is a good short interest ratio for CRISPR Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRSP shares currently have a short interest ratio of 8.0. Learn More on CRISPR Therapeutics's short interest ratio.

Which institutional investors are shorting CRISPR Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CRISPR Therapeutics: IMC Chicago LLC, IMC Chicago LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is CRISPR Therapeutics' short interest increasing or decreasing?

CRISPR Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 14,760,000 shares, an increase of 0.3% from the previous total of 14,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CRISPR Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to CRISPR Therapeutics: Halozyme Therapeutics, Inc. (6.28%), Krystal Biotech, Inc. (7.61%), Immunovant, Inc. (14.92%), ImmunityBio, Inc. (41.52%), Revolution Medicines, Inc. (7.29%), Iovance Biotherapeutics, Inc. (21.08%), SpringWorks Therapeutics, Inc. (14.45%), Vaxcyte, Inc. (7.59%), Apogee Therapeutics, Inc. (13.11%), Arcellx, Inc. (9.85%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short CRISPR Therapeutics stock?

Short selling CRSP is an investing strategy that aims to generate trading profit from CRISPR Therapeutics as its price is falling. CRSP shares are trading up $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CRISPR Therapeutics?

A short squeeze for CRISPR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRSP, which in turn drives the price of the stock up even further.

How often is CRISPR Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRSP, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CRSP) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners